This study is classified as a ‘sleeping study’ . It will be activated if a patient attends the Emergency Department with symptoms relating to rare diseases which may be of public interest within the UK. This is part of a much larger international co-ordination of studies. The study hopes to develop an understanding of disease processes. This includes risk factors for severe illness, and the development of new treatments.

https://www.medsci.ox.ac.uk/news/international-research-consortium-activates-ncov-clinical-study